Generation Lab claims to have developed a drug called 1-Generation that rejuvenates blood and tissues by combining two existing drugs. This treatment is marketed as capable of reversing aging effects, though details about the specific drugs remain undisclosed, raising skepticism among experts. Developers should be cautious given the lack of transparency and potential risks associated with unverified longevity therapies.
Read the full article at MIT Tech Review
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



